Antibodies and Dextran as Anti-Tumour Drug Carriers
- 1 January 1982
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cellsNature, 1981
- Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.Proceedings of the National Academy of Sciences, 1980
- Higher Antitumor Efficacy of Daunomycin When Linked to Dextran: In Vivo and In Vitro Studies 2JNCI Journal of the National Cancer Institute, 1978
- Characterization of a carcinogen‐induced murine B lymphocyte cell line of C3H/eB originEuropean Journal of Immunology, 1977
- The cardiotoxicity of adriamycin and daunomycin in childrenCancer, 1976
- Protection of Mice Against Syngeneic LymphomataBritish Journal of Cancer, 1974
- The cure and concomitant immunization of mice bearing Ehrlich ascites tumors by treatment with an antibody-alkylating agent complexPublished by Elsevier ,1973
- Thymus and Bone Marrow Derived Lymphatic Leukaemia in MiceNature, 1973
- Prospectus for cancer chemotherapyCancer, 1972
- Immunochemotherapy of Cancer with Chlorambucil-carrying AntibodyBMJ, 1972